Tag: Cannasouth

Business

New Zealand’s Medical Cannabis Market Growth Slows as Major Operator Calls in Administrators

New Zealand’s medical cannabis market grew a further 25% in 2025, according to the latest official figures, seeing the country

Ben Stevens March 24, 2026

A THREE-YEAR neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing debilitating neuropathic pain, which affects about 400,000 New Zealanders or 8 per cent of the country’s population.

Press releases

Cannasouth Research Shows Cannabinoids Could Provide Relief For Thousands Of New Zealanders From Debilitating Neuropathic Pain

A THREE-YEAR neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing

Tag: Cannasouth

New Zealand’s Medical Cannabis Market Growth Slows as Major Operator Calls in Administrators

Cannasouth Research Shows Cannabinoids Could Provide Relief For Thousands Of New Zealanders From Debilitating Neuropathic Pain

CONNECT

Subscribe to our mailing list to receives daily updates!

Categories

Browse by Tags

Contact us

Categories

Editions

Business of cannabis

Popular

Recent Searches

Popular Searches

Recent Searches

Popular Searches

Tag: Cannasouth

New Zealand’s Medical Cannabis Market Growth Slows as Major Operator Calls in Administrators

Cannasouth Research Shows Cannabinoids Could Provide Relief For Thousands Of New Zealanders From Debilitating Neuropathic Pain

CONNECT

Subscribe to our mailing list to receives daily updates!

Categories

Browse by Tags